Summary
Chronic inflammation and aberrant lipid metabolism represent hallmarks of atherosclerosis. Innate immunity critically depends upon Toll-like receptor (TLR) signalling. Recent data directly implicate signalling by TLR4 and TLR2 in the pathogenesis of atherosclerosis. The role that TLRs play in the pathogenesis of atherosclerosis can be assessed by using several animal models, which provide a double genetic deficiency in TLRs and molecules implicated in the lipid metabolism, such as ApoE or LDL receptor. Furthermore, a more recent technique, such as the bone marrow transplantation (BMT), can be a useful and straightforward method to elucidate the role of stromal versus hematopoietic cells in the acceleration of the atheroma.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Munro JM, Contran RS (1988) Pathogenesis of atherosclerosis: atherogenesis and inflammation. Lab Invest; 58(3):249–61
Wautier JL (1989) Monocyte-endothelium relations. J Mal Vasc; 14 Suppl A:13–6
Yilmaz A, Lochno M, Traeg F, Cicha I, Reiss C, Stumpf C, Raaz D, Anger T, Amann K, Probst T, Ludwig J, Daniel WG, Garlichs CD (2004) Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis; 176(1):101–10
Kawahara I, Kitagawa N, Tsutsumi K, Nagata I, Hayashi T, Koji T (2007) The expression of vascular dendritic cells in human atherosclerotic carotid plaques. Human Pathol; 38(9):1378–85
Soilleux EJ, Morris LS, Trowsdale J, Coleman N, Boyle JJ (2002) Human atherosclerotic plaques express DC-SIGN, a novel protein found on dendritic cells and macrophages. J Pathol; 198(4):511–6. 5, 6
Kis Z, Pallinger E, Endresz V, Burian K, Jelinek I, Gonczol E, Valyi-Nagy I (2004) The interactions between human dendritic cells and microbes: possible clinical applications of dendritic cells. Inflamm Res; 53:413–23
Bobryshev YV, Cao W, Phoon MC, Tran D, Chow VT, Lord RS, Lu J (2004) Detection of Chlamydophila pneumoniae in dendritic cells in atherosclerotic lesions. Atherosclerosis; 173:185–95
Mendall, MA, Goggin PM, Molineaux N, Levy J, Toosy T, trachan D, Camm AJ, Northfield TC (1994) Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J; , 71:437
Yamashiroya HM, Ghosh L, Yang R, Robertson AL, Jr. (1988). Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol; 130:71
Horvath R, Cerny J, Benedik J, Jr., Hokl J, Jelinkova I, Benedik J (2000) The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J Clin Virol; 16:17
Bobryshev YV (2000) Identification of HIV-1 in the aortic wall of AIDS patients. Atherosclerosis; 152:529
Hajjar DP, Pomerantz KB, Falcone DJ, Weksler BB, Grant AJ (1987) Herpes simplex virus infection in human arterial cells: implications in arteriosclerosis. J Clin Invest; 80:1317
Raza-Ahmad A, Klassen GA, Murphy DA, Sullivan JA, Kinley CE, Landymore RW, Wood JR (1995) Evidence of type 2 herpes simplex infection in human coronary arteries at the time of coronary artery bypass surgery. Can J Cardiol; 11:1025
Ishizaka N, Ishizaka Y, Takahashi E, Tooda E,t Hashimoto H, Nagai R, Yamakado M (2002) Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet; 359:133
Vassalle C,, Masini S, Bianchi F, Zucchelli GC (2004) Evidence for association between hepatitis C virus seropositivity and coronary artery disease. Heart; 90:565
Ford PJ et al (2007) Cardiovascular and oral disease interactions: what is the evidence? Prim Dent Care; 14(2):59–66
17 Lehr HA, Sagban TA, Ihling C, Zahringer U, Hungerer KD, Blumrich M, Reifenberg K, Bhakdi S (2001) Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation; 104:914
Xu XH, Shah PK, Faure E, Equils O, Thomas L, Fishbein MC, Luthringer D, Xu XP, Rajavashisth TB, Yano J, Kaul S, Arditi M (2001) Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerosis plaques and upregulated by oxidized LDL. Circulation; 104:3103
Edfelt K, Swedenborg J, Hansson GK, Yan ZQ (2002) Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation. Circulation; 105:1158
Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB, Arditi M (2004) Lack of Toll like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. PNAS; 101(29):10679–84
Mullick AE, Tobias PS, Curtiss LK (2005) Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest; 115:3149–56
Liu X, Ukai T, Yumoto H, Davey M, Goswami S, Gibson FC, Genco CA (2007) Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids. Atherosclerosis; 196(1):146–54
Ishida BY, Blanche PJ, Nichols AV, Yashar M, Paigen B (1991) Effects of atherogenic diet consumption on lipoproteins in mouse strain C57BL/6 and C3H. J Lipid Res; 32:559
Shi W, Haberland ME, Jien ML, Shih DM, Lusis AJ (2000) Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice. Circulation; 102:75
Shi W, Wang X, Tangchitpiyanond K, Wong J, Shi Y, Lusis AJ (2002) Atherosclerosis in C3H/HeJ mice reconstituted with apolipoprotein E-null bone marrow. Arterioscler Thromb Vasc Biol; 22:650
Ishibashi S, Herz J, Maeda N, Goldstein JN, Brown MS (1994) The two-receptor model of clearance of lipoproteins: tests of hypothesis in “knockout” mice lacking the low density lipoprotein receptor, apolipoprotein E, or both proteins. PNAS; 91(10):4431–5
Cogger VC, Hilmer SN, Sullivan D, Muller M, Fraser R, Le Couteur DG (2006) Hyperlipidemia and surfactants: the liver sieve is a link Atherosclerosis.189(2):273–81.
Veniant MM, Sullivan MA, Kim SK, Ambriosiak P, Chu A, Wilson MD, Hellerstein MK, Rudel LL, Walzem RL, Young SG (2000) Defining the atherogenesis of large and small lipoproteins containing apolipoprotein B100. J Clin Invest; 106(12):1501–10
Cui YZ, Hisha H, Yang GX, Fan TX, Jin T, Li Q, Lian Z, Ikehara S (2002) Optimal protocol for total body irradiation for allogeneic bone marrow transplantation in mice. Bone Marrow Transplant; 30(12):843–9
Salomon O, Lapidot T, Terenzi A et al (1990) Induction of donor-type chimerism in murine recipients of bone marrow allografts by different radiation regimens currently used in treatment of leukaemia patients. Blood; 76:1872–8
Soderling CCB, Song CW, Blazar BR, Vallera DA (1985) A correlation between conditioning and engraftment in recipient MHC-mismatched T cell depleted murine bone marrow transplants. J Immunol; 135:941–6
Zeng BD, Lewis D, Sussan Dejbakhsh-Jones FL, Garcia-Ojeda M, Sibley R, Strober SB (1999) Bone marrow NK1.1– and NK1.1 + Tcells reciprocally regulate acute graft versus host disease. J Exp Med; 189:1073–81
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science + Business Media, LLC
About this protocol
Cite this protocol
Sorrentino, R., Arditi, M. (2009). Innate Immunity, Toll-Like Receptors, and Atherosclerosis: Mouse Models and Methods. In: McCoy, C.E., O’Neill, L.A.J. (eds) Toll-Like Receptors. Methods in Molecular Biology™, vol 517. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59745-541-1_23
Download citation
DOI: https://doi.org/10.1007/978-1-59745-541-1_23
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-934115-72-5
Online ISBN: 978-1-59745-541-1
eBook Packages: Springer Protocols